| Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a … AE Place, KE Stevenson, LM Vrooman, MH Harris, SK Hunt, JE O'Brien, ... The lancet oncology 16 (16), 1677-1690, 2015 | 229 | 2015 |
| Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana‐Farber Cancer Institute ALL Consortium Protocols (2000–2010) K Bona, TM Blonquist, DS Neuberg, LB Silverman, J Wolfe Pediatric blood & cancer 63 (6), 1012-1018, 2016 | 100 | 2016 |
| Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent M Xiang, H Kim, VT Ho, SR Walker, M Bar-Natan, M Anahtar, S Liu, ... Blood, The Journal of the American Society of Hematology 128 (14), 1845-1853, 2016 | 95 | 2016 |
| Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001 LM Vrooman, TM Blonquist, MH Harris, KE Stevenson, AE Place, SK Hunt, ... Blood advances 2 (12), 1449-1458, 2018 | 93 | 2018 |
| Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis M Movassaghian, AM Brunner, TM Blonquist, H Sadrzadeh, A Bhatia, ... Leukemia & lymphoma 56 (6), 1698-1703, 2015 | 93 | 2015 |
| Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics DL Berry, TM Blonquist, F Hong, B Halpenny, AH Partridge Patient preference and adherence, 1587-1592, 2015 | 84 | 2015 |
| Polymorphisms in genes related to oxidative stress are associated with inferior cognitive function after therapy for childhood acute lymphoblastic leukemia PD Cole, Y Finkelstein, KE Stevenson, TM Blonquist, V Vijayanathan, ... Journal of Clinical Oncology 33 (19), 2205, 2015 | 73 | 2015 |
| Exposure to a patient-centered, Web-based intervention for managing cancer symptom and quality of life issues: impact on symptom distress DL Berry, TM Blonquist, RA Patel, B Halpenny, J McReynolds Journal of medical Internet research 17 (6), e136, 2015 | 69 | 2015 |
| Risk and timing of cardiovascular death among patients with myelodysplastic syndromes AM Brunner, TM Blonquist, GS Hobbs, PC Amrein, DS Neuberg, ... Blood Advances 1 (23), 2032-2040, 2017 | 61 | 2017 |
| Decision support with the personal patient profile-prostate: a multicenter randomized trial DL Berry, F Hong, TM Blonquist, B Halpenny, CP Filson, VA Master, ... The Journal of urology 199 (1), 89-97, 2018 | 44 | 2018 |
| Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia AT Fathi, SA Wander, TM Blonquist, AM Brunner, PC Amrein, J Supko, ... haematologica 102 (4), 719, 2017 | 44 | 2017 |
| Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia ML Sulis, TM Blonquist, KE Stevenson, SK Hunt, S Kay‐Green, UH Athale, ... Pediatric blood & cancer 65 (5), e26952, 2018 | 43 | 2018 |
| Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia TH Tran, MH Harris, JV Nguyen, TM Blonquist, KE Stevenson, ... Blood Advances 2 (5), 529-533, 2018 | 43 | 2018 |
| Feasibility of using algorithm-based clinical decision support for symptom assessment and management in lung cancer ME Cooley, TM Blonquist, PJ Catalano, DF Lobach, B Halpenny, ... Journal of pain and symptom management 49 (1), 13-26, 2015 | 42 | 2015 |
| Efficacy and toxicity of pegaspargase and calaspargase pegol in childhood acute lymphoblastic leukemia: results of DFCI 11-001 LM Vrooman, TM Blonquist, KE Stevenson, JG Supko, SK Hunt, ... Journal of Clinical Oncology 39 (31), 3496-3505, 2021 | 40 | 2021 |
| Psychosocial outcomes of an electronic self‐report assessment and self‐care intervention for patients with cancer: a randomized controlled trial JR Fann, F Hong, B Halpenny, TM Blonquist, DL Berry Psycho‐Oncology 26 (11), 1866-1871, 2017 | 35 | 2017 |
| Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis AM Brunner, TM Blonquist, H Sadrzadeh, AM Perry, EC Attar, PC Amrein, ... Leukemia research 38 (7), 773-780, 2014 | 34 | 2014 |
| An investigation of toxicities and survival in hispanic children and adolescents with ALL: results from the dana‐farber cancer Institute ALL Consortium protocol 05‐001 JM Kahn, PD Cole, TM Blonquist, K Stevenson, Z Jin, S Barrera, R Davila, ... Pediatric blood & cancer 65 (3), e26871, 2018 | 30 | 2018 |
| Patient-reported symptom distress, and most bothersome issues, before and during cancer treatment F Hong, TM Blonquist, B Halpenny, DL Berry Patient Related Outcome Measures, 127-135, 2016 | 30 | 2016 |
| Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation AT Fathi, TM Blonquist, D Hernandez, PC Amrein, KK Ballen, ... Cancer 124 (2), 306-314, 2018 | 29 | 2018 |
